Cite
Huang KA, Zhou D, Tan TK, et al. Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2. Theranostics. 2022;12(1):1-17doi: 10.7150/thno.65563.
Huang, K. A., Zhou, D., Tan, T. K., Chen, C., Duyvesteyn, H. M. E., Zhao, Y., Ginn, H. M., Qin, L., Rijal, P., Schimanski, L., Donat, R., Harding, A., Gilbert-Jaramillo, J., James, W., Tree, J. A., Buttigieg, K., Carroll, M., Charlton, S., Lien, C. E., Lin, M. Y., Chen, C. P., Cheng, S. H., Chen, X., Lin, T. Y., Fry, E. E., Ren, J., Ma, C., Townsend, A. R., & Stuart, D. I. (2022). Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2. Theranostics, 12(1), 1-17. https://doi.org/10.7150/thno.65563
Huang, Kuan-Ying A, et al. "Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2." Theranostics vol. 12,1 (2022): 1-17. doi: https://doi.org/10.7150/thno.65563
Huang KA, Zhou D, Tan TK, Chen C, Duyvesteyn HME, Zhao Y, Ginn HM, Qin L, Rijal P, Schimanski L, Donat R, Harding A, Gilbert-Jaramillo J, James W, Tree JA, Buttigieg K, Carroll M, Charlton S, Lien CE, Lin MY, Chen CP, Cheng SH, Chen X, Lin TY, Fry EE, Ren J, Ma C, Townsend AR, Stuart DI. Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2. Theranostics. 2022 Jan 01;12(1):1-17. doi: 10.7150/thno.65563. eCollection 2022. PMID: 34987630; PMCID: PMC8690919.
Copy
Download .nbib